Stephen Diggle
InvestorAdvisor at Vulpes Ventures · Head of Investor Relations & Institutional Fundraising at AlbionVC
Find your path to Stephen
42 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.
About
Stephen Diggle has worked in finance since 1986, including 15 years at international investment banks in London, Sydney, and Hong Kong. He co-founded Artradis Fund Management, a Singapore-based hedge fund launched in 2002, and later founded Vulpes Investment Management, a family office-backed investment manager where he serves as one of two portfolio managers with a focus on U.K.-based biotechnology companies. He holds a Master's degree in Philosophy, Politics, and Economics from the University of Oxford.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 1
Oxford BiodynamicsBoard seat
via Vulpes Ventures · filed Nov 2021 · $5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Oxford BiomedicaScancell
Sources: SEC Form D filings · the firm's website.
Colleagues at Vulpes Ventures
Frequently asked questions
- Who is Stephen Diggle?
- Stephen Diggle has worked in finance since 1986, including 15 years at international investment banks in London, Sydney, and Hong Kong. He co-founded Artradis Fund Management, a Singapore-based hedge fund launched in 2002, and later founded Vulpes Investment Management, a family office-backed investment manager where he serves as one of two portfolio managers with a focus on U.K.-based biotechnology companies. He holds a Master's degree in Philosophy, Politics, and Economics from the University of Oxford.
- Where does Stephen Diggle work?
- Stephen Diggle is Advisor at Vulpes Ventures.
- What does Stephen Diggle invest in?
- Stephen Diggle invests in Biotech.
- What boards does Stephen Diggle sit on?
- Stephen Diggle holds tracked board seats at Oxford Biodynamics.
- What companies has Stephen Diggle invested in?
- Investments tracked here include Oxford Biomedica, Scancell.